000 -LEADER |
fixed length control field |
01520cam a2200265 a 4500 |
001 - CONTROL NUMBER |
control field |
vtls003223733 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
MY-SjTCS |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20200226114956.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
110921s2011 njua b 001 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780470232927 (hbk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780470939918 (obk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780470939871 (ePDF) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781118002254 (ePub) |
039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE] |
Level of rules in bibliographic description |
201112131044 |
Level of effort used to assign nonsubject heading access points |
wilmina |
Level of effort used to assign subject headings |
201111301122 |
Level of effort used to assign classification |
izani |
-- |
201109211214 |
-- |
malathy |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1 |
Item number |
PRA 2011 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Prazeres, Duarte Miguel F. |
9 (RLIN) |
56004 |
245 10 - TITLE STATEMENT |
Title |
Plasmid biopharmaceuticals : |
Remainder of title |
basics, applications, and manufacturing / |
Statement of responsibility, etc. |
Duarte Miguel F. Prazeres. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Hoboken, N.J. : |
Name of publisher, distributor, etc. |
John Wiley, |
Date of publication, distribution, etc. |
c2011. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xix, 590 p. : |
Other physical details |
ill. ; |
Dimensions |
25 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Historical perspective -- Gene transfer with plasmid biopharmaceuticals -- Product and process development -- Structure -- Analytical characterization -- Delivery -- Ethical and safety issues -- Human and veterinary markets -- Human case studies : pandemic influenza and critical limb ischaemia -- Veterinary case studies : West Nile, infectious hematopoietic necrosis, and melanoma -- GMPS and validation -- Product specifications and quality control -- Cell culture -- An overview of downstream processing -- Primary isolation -- Intermediate recovery -- Final purification -- Process synthesis -- Concluding remarks and outlook. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Plasmids. |
9 (RLIN) |
56005 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biopharmaceutics. |
920 ## - Programme |
Programme |
PHA : 172681 |
999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
Koha biblionumber |
141167 |
Koha biblioitemnumber |
141167 |